Detalhe da pesquisa
1.
Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.
J Genet Couns
; 26(6): 1280-1291, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28540621